AUSPERBIO
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treat a wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
AUSPERBIO
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.ausperbio.com
Total Employee:
101+
Status:
Active
Total Funding:
50.67 M USD
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Investors List
BioVenture
BioVenture investment in Series A - AusperBio
Genesis Capital
Genesis Capital investment in Series A - AusperBio
InnoPinnacle Fund
InnoPinnacle Fund investment in Series A - AusperBio
Qiming Venture Partners
Qiming Venture Partners investment in Series A - AusperBio
Hankang Capital
Hankang Capital investment in Series A - AusperBio
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-03 | AusperBio Welcomes Dr. Will Wei as Head of CMC |
Official Site Inspections
http://www.ausperbio.com
- Host name: 47.246.24.187
- IP address: 47.246.24.187
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "AusperBio"
AusperBio - Crunchbase Company Profile & Funding
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide …See details»
AusperBio - LinkedIn
AusperBio is a clinical-stage biopharmaceutical company with operations in the USA and China, dedicated to advancing oligonucleotide and targeted delivery technologies for transformative …See details»
Ausperbio
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing oligonucleotide therapeutics. Leveraging our innovative and proprietary Med-Oligo™ ASO platform with …See details»
AusperBio - The Org
AusperBio is a clinical-stage biopharmaceutical company with operations in the USA and China, dedicated to advancing oligonucleotide and targeted delivery technologies for transformative …See details»
AusperBio 2025 Company Profile: Valuation, Funding & Investors
AusperBio General Information Description. Provider and developer of small interfering ribonucleic acid (siRNA) drugs designed for hepatitis B. The company focuses on innovative treatments …See details»
AusperBio Company Profile - Office Locations, Competitors ... - Craft
AusperBio is a biopharmaceutical company that develops therapies for hepatitis B (HBV) treatment. It offers Med-Oligo ASO, a technology platform that enhances antisense …See details»
Ausperbio Therapeutics Inc. Company Profile | San Mateo, CA ...
Find company research, competitor information, contact details & financial data for Ausperbio Therapeutics Inc. of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»
Ausper Biopharma Co., Ltd. - Drug pipelines, Patents
Apr 11, 2025 — Max Gelman AusperBio raised a $73 million Series B round led by HanKang Capital, the proceeds of which will fund mid-stage development of its lead candidate AHB-137. ... The statistics for drugs in the Pipeline is the …See details»
AusperBio Therapeutics, Inc. (AusperBio Therapeutics, Inc.) - 药物 …
Jan 23, 2025 AusperBio is committed to delivering patient-centered innovations, aiming to alleviate the global health burden of CHB and transform treatment paradigms for this serious …See details»
Contact us - Ausperbio
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing oligonucleotide therapeutics. Leveraging our innovative and …See details»
AusperBio Company Profile | Management and Employees List
AusperBio Profile and History. AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing oligonucleotide therapeutics. …See details»
Ausper Biopharma | VentureRadar
AusperBio is a clinical-stage biopharmaceutical company with operations in China and the USA, dedicated to the development of innovative, best-in-class therapeutics for curing HBV …See details»
AusperBio - Products, Competitors, Financials, Employees, …
AusperBio is a clinical-stage biotechnology company focused on developing oligonucleotide therapies for treating chronic hepatitis B. The company's main offerings include a proprietary …See details»
AusperBio - Overview, News & Similar companies | ZoomInfo.com
Dec 26, 2024 AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing oligonucleotide therapeutics. Leveraging …See details»
AusperBio - Funding, Financials, Valuation & Investors - Crunchbase
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases. New. Resources. ... How much funding has this …See details»
Org Chart AusperBio - The Official Board
AusperBio has 7 executives. AusperBio; Please confirm your deletion . Delete or Cancel . Unfortunately, you don't own enough credit to see this new org chart. To continue, you can …See details»
AusperBio - app.biopharmiq.com
About: AusperBio is a clinical-stage biopharmaceutical company with operations in the USA and China, dedicated to the development of innovative therapeutics for curing chronic hepatitis B. …See details»
Ausper Biopharma - VentureRadar
AusperBio is a clinical-stage biopharmaceutical company with operations in China and the USA, dedicated to the development of innovative, best-in-class therapeutics for curing HBV …See details»
AusperBio CEO and Key Executive Team | Craft.co
AusperBio's Co-Founder & Chief Executive Officer is Guofeng Cheng. Other executives include Chris Yang, Co-Founder & Chief Strategy Officer; Yang Tian, Senior Vice President, Research …See details»
AusperBio Presents Interim Phase IIb AHB-137 Clinical Data in a …
1 day ago AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today announced the presentation of end-of-treatment …See details»